PTHS vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

PTHS

47.1
AI Score
VS
PTHS Wins

NIVF

33.6
AI Score

Investment Advisor Scores

PTHS

47score
Recommendation
HOLD

NIVF

34score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric PTHS NIVF Winner
Forward P/E 0 0.0015 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% -4.7% PTHS
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 47.1/100 33.6/100 PTHS
Profit Margin -199.5% 24.2% NIVF
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY PTHS

Relative Price Performance (Last 90 Days)

PTHS 1M: -54.4% · 3M: -69.2% NIVF 1M: +19.9% · 3M: -46.0%

Current Technical Phase

PTHS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -20.2%), weak momentum, RSI 26

RSI (14): 26.4 · Price: $8.90

NIVF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.1 · Price: $0.28

Fundamentals Snapshot

Metric PTHS NIVF
Market Cap — —
Forward P/E -1.7 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.8% 0.2%
Operating Margin -1.0% -1.8%
EPS -27.53 -34064.71
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PTHS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.